
19.39 Delayed Data As of Mar 20 | ![]() Today’s Change | 9.86 Today|||52-Week Range 32.45 | -2.07% Year-to-Date |
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates Mar 08 / Zacks.com - Paid Partner Content |
Previous close | 18.94 |
Today’s open | 19.14 |
Day’s range | 18.68 - 19.49 |
Volume | 304,213 |
Average volume (3 months) | 469,134 |
Market cap | $649.1M |
Earnings growth (last year) | -15.29% |
Earnings growth (this year) | -1.17% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -24.38% |
P/E ratio | NM |
Price/Sales | 263.85 |
Price/Book | 3.06 |
Today’s change | Today’s % change | |
---|---|---|
BCYCBicycle Therapeutics... | -0.42 | -1.93% |
ADMAADMA Biologics Inc | -0.02 | -0.65% |
IBRXImmunitybio Inc | -0.06 | -4.26% |
---- |
Next reporting date | May 10, 2023 |
EPS forecast (this quarter) | -$0.67 |
Annual revenue (last year) | $3.8M |
Annual profit (last year) | -$69.2M |
Net profit margin | -1,814.95% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |